Literature DB >> 10790207

Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease.

T Okada1, Y Shiono, H Hayashi, H Satoh, T Sawada, A Suzuki, Y Takeda, M Yano, K Michitaka, M Onji, H Mabuchi.   

Abstract

The gene ATP7B responsible for Wilson's disease (WD) produces a protein which is predicted to be a copper-binding P-type ATPase, homologous to the Menkes disease gene (ATP7A). Various mutations of ATP7B have been identified. This study aimed to detect disease-causing mutations, to clarify their frequency and distribution, to determine whether genotype correlates with phenotype, and to determine the rate of abnormal findings in heterozygotes for the WD gene. We analyzed 41 unrelated Japanese WD families, including 47 patients. Twenty-one mutations, including nine novel ones, were identified. 2871delC (15.9%), 1708-5T-->G (11. 0%), and Arg778Leu (13.4%) were the most common mutations. 2871delC was detected mainly in eastern Japan and 1708-5T-->G in western Japan. The homozygotes for the 1708-5T-->G, 2871delC, or Arg778Leu mutations did not show a correlation with their phenotypes. Ceruloplasmin and copper levels were abnormally low in 28.6% and 35. 0% of heterozygotes, respectively. When patients and their families are screened for WD, a high rate of abnormal laboratory data in heterozygotes must be taken into account. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790207     DOI: 10.1002/(SICI)1098-1004(200005)15:5<454::AID-HUMU7>3.0.CO;2-J

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

Review 1.  Compound overload of copper and iron in patients with Wilson's disease.

Authors:  Hisao Hayashi; Motoyoshi Yano; Yoshikazu Fujita; Shinya Wakusawa
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

2.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

Review 3.  Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.

Authors:  Peter Ferenci
Journal:  Hum Genet       Date:  2006-06-22       Impact factor: 4.132

Review 4.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

5.  Carrier frequency of Wilson's disease in the Korean population: a DNA-based approach.

Authors:  Ja-Hyun Jang; Taeheon Lee; Sunghee Bang; Young-Eun Kim; Eun-Hae Cho
Journal:  J Hum Genet       Date:  2017-05-18       Impact factor: 3.172

Review 6.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

Review 7.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

8.  High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease.

Authors:  Laimutis Kucinskas; Jolanta Jeroch; Astra Vitkauskiene; Raimundas Sakalauskas; Vitalija Petrenkiene; Vaidutis Kucinskas; Rima Naginiene; Hartmut Schmidt; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

9.  Identification of two novel mutations in the ATP7B gene that cause Wilson's disease.

Authors:  Hong-Wen Zhu; Zhong-Bin Tao; Gang Su; Qiao-Ying Jin; Liang-Tao Zhao; Jia-Rui Zhu; Jun Yan; Tian-Yu Yu; Jie-Xian Ding; Yu-Min Li
Journal:  World J Pediatr       Date:  2017-08-15       Impact factor: 2.764

10.  Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease.

Authors:  Uta Merle; Karl Heinz Weiss; Christoph Eisenbach; Sabine Tuma; Peter Ferenci; Wolfgang Stremmel
Journal:  BMC Gastroenterol       Date:  2010-01-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.